Search Results 941-950 of 17889 for monoclonal antibody
... monoclonal anti-CD20 antibody, for patients with relapsed or refractory B Cell non-Hodgkin lymphoma (NHL). Phase 1 Study To Investigate TCRTs KRAS ...
... monoclonal antibody that targets CD38, a protein found on the surface of myeloma cells, significantly reduces the risk of progression to active multiple ...
... antibody can't bind to it or binds less tightly. ... Badley, could reduce or nullify beneficial effects of therapies that rely heavily on antibodies: monoclonal ...
The anti-CD52 monoclonal antibody alemtuzumab reduces disease activity in previously untreated patients with relapsing-remitting multiple sclerosis. We ...
Physicians at Mayo Clinic have used rituximab, a monoclonal antibody directed against the CD20 antigen on the surface of B lymphocytes, to treat patients with ...
The purpose of this study is to evaluate the utility of using anti-HLA antibody titer to measure the effectiveness of antibody lowering therapy (i.e. ...
The purpose of this study is to determine the efficacy of pembrolizumab in patients with advanced sarcomas. Participation eligibility. Participant eligibility ...
A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin ...
... monoclonal antibody is deemed appropriate). • Recommendation by the treating provider to initiate therapy with a commercially available, FDA approved, anti ...
About this study. The purpose of this study is to see: 1. If using these two drugs (carfilzomib and belatacept) together is safe
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!